Abstract

AbstractNear infrared (NIR) light, especially NIR‐II, triggered photothermal therapy has gained increasing attention due to its deep tissue penetration ability. The development of new NIR‐II photothermal agent may accelerate the clinical translation. As a semiconductor, bismuth (Bi) can be activated by NIR‐II light. Herein, we developed Bi@bismuth sulfide (Bi2S3) core@shell nanoparticles (NPs) as new NIR‐II triggered PTA. The photothermal conversion efficiency of Bi@Bi2S3 NPs was calculated to be 48.39 %. With 1064 nm laser irradiation, Bi@Bi2S3 NPs could effectively induce temperature elevation and kill cancer cells. In vivo experiments further prove that Bi@Bi2S3 NPs can serve as an efficient photothermal agent with well biocompatibility for tumor elimination.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call